From the Press Release: Ahmedabad-based Intas Pharma, one of India’s leading private pharmaceutical companies, today announced that it is raising Rs. 300 crores from ChrysCapital in a pre-IPO round. The Company has deferred its listing plans for the time being and intends to re-file for an IPO once market conditions stabilize. Intas is an established global pharmaceutical player with FY 2012 revenues of over Rs. 2,700 crores. The Company has a strong presence in chronic therapy areas and is currently ranked 12 th in the domestic market by ORG-IMS. Intas also has a fast growing and significant export base in Europe and USA under the brand name of Accord Healthcare. This will be ChrysCapital ’s second investment in Intas, having originally backed the Company in 2006 from an older fund. As an existing investor in the Company, ChrysCapital has benefited significantly from the strong performance recorded by Intas over the past six years. Consequently